fentanyl has been researched along with Acquired Immunodeficiency Syndrome in 4 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Excerpt | Relevance | Reference |
---|---|---|
"This prospective, open-label, before-after trial was designed to compare the efficacy of oral opioids with that of transdermal fentanyl in severe AIDS-related chronic pain, as well as assess barriers, patient satisfaction, and side effects." | 7.71 | Transdermal fentanyl for chronic pain in AIDS: a pilot study. ( Lefkowitz, M; Newshan, G, 2001) |
"This prospective, open-label, before-after trial was designed to compare the efficacy of oral opioids with that of transdermal fentanyl in severe AIDS-related chronic pain, as well as assess barriers, patient satisfaction, and side effects." | 3.71 | Transdermal fentanyl for chronic pain in AIDS: a pilot study. ( Lefkowitz, M; Newshan, G, 2001) |
"Both buprenorphine and fentanyl were well tolerated." | 1.39 | Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients. ( Cannata, F; Canneti, A; Di Marco, P; Luzi, M; Pasqualitto, F; Reale, C; Spinoglio, A, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canneti, A | 1 |
Luzi, M | 1 |
Di Marco, P | 1 |
Cannata, F | 1 |
Pasqualitto, F | 1 |
Spinoglio, A | 1 |
Reale, C | 1 |
Eroglu, A | 1 |
Newshan, G | 1 |
Lefkowitz, M | 1 |
Prinscott, J | 1 |
4 other studies available for fentanyl and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Analgesics, Opioid; Buprenorphine; CD4-CD8 Ratio; Female; | 2013 |
Current developments in the treatment of neuropathic pain in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Buprenorphine; Female; Fentanyl; Humans; Mal | 2013 |
Transdermal fentanyl for chronic pain in AIDS: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Cutaneous; Adult; Analgesics, Opioid; Chronic Di | 2001 |
Anesthetic consideration in a patient with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Cranial | 1986 |